Initiation of ARNi and SGLT2i in Patients With HFrEF
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:October 23, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Heart Failure With Reduced Ejection FractionLast Updated:October 23, 2023Recruiting
Condition(s):Hepatitis C Virus Infection; Hepatitis C Virus Infection, Response to Therapy of; Hemodialysis ComplicationLast Updated:February 24, 2021Unknown status
Condition(s):Chronic Kidney DiseaseLast Updated:October 6, 2006Terminated
Condition(s):IgA NephropathyLast Updated:November 3, 2022Active, not recruiting
Condition(s):Fabry DiseaseLast Updated:September 24, 2021Unknown status
Condition(s):Living Donors; Nephrectomy; KidneyLast Updated:January 12, 2024Active, not recruiting
Condition(s):Renal Dysfunction; HypertensionLast Updated:November 9, 2012Completed
Condition(s):End Stage Renal Disease on Dialysis; Peritoneal Dialysis; HemodialysisLast Updated:September 23, 2021Unknown status
Condition(s):Urothelial Carcinoma; Bladder Cancer; Urothelial Neoplasm; Urothelial Carcinoma Bladder; Urothelial Carcinoma in SituLast Updated:May 9, 2022Recruiting
Condition(s):Chronic Renal Disease and Nephrotic SyndromeLast Updated:January 31, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.